UiPath Suffers AI Token Fears, Discounted Growth Prospects Trigger Reiterated Buy
PATH's term licensing/per-seat SaaS model avoids unpredictable AI token costs while providing deterministic orchestration that complements the growing Agentic AI use. Combined with the expanded ecosystem partnership and the forward-deployed engineering program, it is unsurprising that the company has reported accelerated backlog growth. FQ1'27 brings forth PATH's ARR growth to $1.9B (+12.2% YoY), expanded operating margins to 22%, and first-ever Q1 GAAP profitability, with it supporting the raised FY2027 guidance.
UiPath: Overlooked Company With Visible Automation Tailwinds
UiPath is delivering accelerating revenue growth and rising ARR, benefiting from the broader AI-driven business transformation. Despite a strong Q1 beat-and-raise, PATH shares remain down ~30% YTD, creating a compelling entry point. PATH's ARR nears $2 billion, outpacing full-year revenue guidance and providing strong demand visibility.
Surging Earnings Estimates Signal Upside for UiPath (PATH) Stock
UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
UiPath: Agentic AI Overhang Overshadows 71% Incremental Profit Margins
UiPath demonstrates resilient revenue growth and significant margin expansion, despite lacking clear agentic AI leadership. PATH's net cash balance sheet and low 3.3x sales multiple provide strong financial and valuation support. Management guides for 12.2% YoY ARR growth next quarter, with AI-related expansion deals significantly larger than non-AI deals.
Which Robotics Stock Most Likely Gets Acquired? 3 Targets Wall Street Is Watching
The robotics industry is consolidating. Large platform companies now treat robots as a real distribution channel for compute, logistics software, and last-mile economics.
Here's Why UiPath (PATH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UiPath Stock Slides 27% YTD: Is PATH a Buy, Hold, or Sell?
PATH's 27% YTD slide reflects investor caution as UiPath expands AI orchestration capabilities amid rising competition.
UiPath (PATH) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UiPath, Inc. (PATH) Presents at 46th Annual William Blair Growth Stock Conference Transcript
UiPath, Inc. (PATH) Presents at 46th Annual William Blair Growth Stock Conference Transcript
UiPath: Can RPA And Agentic AI Coexist And Thrive? (Downgrade)
UiPath: Can RPA And Agentic AI Coexist And Thrive? (Downgrade)
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath Q1 Earnings In Line With Estimates, Revenues Increase Y/Y
PATH tops Q1 FY27 estimates as AI-driven automation demand boosts ARR growth, enterprise expansion deals and profitability gains.
